Home › Schizophrenia › Tennessee
Schizophrenia clinical trials in Tennessee
6 studies for Schizophrenia are looking for participants at sites in Tennessee.
Cities in Tennessee
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
- Local Institution - 0113, Nashville
RecruitingPhase 3
Ages 13 to 17 · All sexes · Updated Nov 12, 2026 · NCT07288567A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Local Institution - 0137, Nashville
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Nov 6, 2026 · NCT07424404Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Access Clinical Trials, Nashville
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Nov 3, 2026 · NCT06229210Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
- Local Institution - 0051, Cordova
- Psychiatric Consultants, Pc, Franklin
- Local Institution - 0066, Nashville
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT07379827Volatility in Paranoia (VIP) Trial: An RCT of Changes in Volatility With Psychotherapy
- Vanderbilt University Medical Center, Nashville
Recruiting
Ages 18 to 65 · All sexes · Updated Sep 30, 2026 · NCT06835556Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia
- Vanderbilt Psychiatric Hospital, Nashville
RecruitingHealthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Jun 2, 2026 · NCT07196462From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.